Novel High-affinity Aβ-binding peptides identified by an advanced in vitro evolution, progressive library method

Protein and Peptide Letters

Volumn 18, Issue 6, 2011, Pages 642-650

  Tsuji Ueno, Sachika ^a   Komatsu, Masayuki ^a   Iguchi, Kakeru ^a   Takahashi, Masahiro ^a   Yoshino, Syuhei ^a   Suzuki, Miho ^a   Nemoto, Naoto ^a   Nishigaki, Koichi ^a  

^a SAITAMA UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; ; Amyloid ; cDNA display; In vitro evolution; Peptide aptamer; Progressive Library method

Indexed keywords

EID: 79953298973     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986611795222678     Document Type: Article

References (22)

1. Hardy, J.A.; Higgins, G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science, 1992, 256, 184-185
2. Lue, L.F.; Kuo, Y.M.; Roher, A.E. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am. J. Pathol., 1999, 155, 853-862 (Pubitemid 29426831)
3. McLean, C.A.; Cherny, R.A.; Fraser, F.W. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann. Neurol., 1999, 46, 860-866
4. Haroutunian, J. V.; Mohs, R. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. J. Am. Med. Assoc., 2000, 283, 1571-1577 (Pubitemid 30161512)
5. Stin, W.B.; Dahlgren, K.N.; Krafft, G.A.; LaDu, M.J. In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis. J. Biol. Chem., 2003, 278, 11612-11622 (Pubitemid 36792723)
6. Bitan, G.; Kirkitadze, M.D.; Lomakin, A.; Vollers, S.S.; Benedek, G.B.; Teplow, D.B. Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. USA, 2003, 100, 330-335 (Pubitemid 36078074)
7. Hoshi, M.; Sato, M.; Matsumoto, S.; Noguchi, A.; Yasutake, K.; Yoshida, N.; Sato, K. Spherical aggregates of β-amyloid (amylosheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β. Proc. Natl. Acad. Sci. USA, 2003, 100, 6370-6375 (Pubitemid 36666588)
8. Lambert, M.P.; Barlow, A.K.; Chromy, B.A.; Edwards, C.; Freed, R.; Liosatos, M.; Morgan, T.E.; Rozovsky, I.; Trommer, B.; Viola, K.L.; Wals, P.; Zhang, C.; Finch, C.E.; Krafft, G.A.; Klein, W.L. Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA, 1998, 95, 6448-6453
9. Lesne, S.; Koh, M.T.; Kotilinek, L.; Kayed, R.; Glabe, C.G.; Yang, A.; Gallagher, M.; Ashe, K.H. A specific amyloid-β protein assembly in the brain impairs memory. Nature, 2006, 440, 352-357
10. Harper, J.D.; Wong, S.S.; Lieber, C.M.; Lansbury, P.T. Observation of metastable Aβ amyloid protofibrils by atomic force microscopy. Chem. Biol., 1997, 4, 119-125 (Pubitemid 27161750)
11. Walsh, D.M.; Lomakin, A.; Benedek, G.B.; Condron, M.M.; Teplow, D.B. Amyloid β-Protein Fibrillogenesis. J. Biol. Chem., 1997, 272, 22364-22372
12. Fradinger, E.A.; Monien, B.H.; Urbance, B.; Lomakin, A.; Tan, M.; Li, H.; Spring, S.M.; Condron, M.M.; Cruz, L.; Xie, C.W.; Benedek, G.B.; Bitan, G. C-terminal peptides coassemble into Aβ42 oligomers and protect neurons against Aβ42-induced neurotoxicity. Proc. Natl. Acad. Sci. USA, 2008, 105, 14175-14180
13. Matharu, B.; El-Agnaf, O.; Razvi, A.; Austen, B.M. Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease. Peptides, 2010, 31, 1866-1872
14. Kitamura, K.; Yoshida, C.; Kinoshita, Y.; Kadowaki, T.; Takahashi, Y.; Tayama, T.; Kawakubo, T.; Naimuddin, M.; Salimullah, M.; Nemoto, N.; Hanada, K.; Husimi, Y.; Yamamoto, K.; Nishigaki, K. Development of systemic in vitro evolution and its application to generation of peptide-aptamer-based inhibitors of cathepsin E. J. Mol. Biol., 2009, 387, 1186-1198
15. Biyani, M.; Husimi, Y.; Nemoto, N. Solid-phase translation and RNA-protein fusion: a novel approach for folding quality control and direct immobilization of proteins using anchored mRNA. Nucleic Acids Res., 2006, 34, e140
16. Tabuchi, I.; Soramoto, S.; Nemoto, N.; Husimi, Y. An in vitro DNA virus for in vitro protein evolution. FEBS Lett., 2001, 508, 309-312 (Pubitemid 33135460)
17. Kitamura, K.; Kinoshita, Y.; Narasaki, S.; Nemoto, N.; Husimi, Y.; Nishigaki, K. Construction of block-shuffled libraries of DNA for evolutionary protein engineering: Y-ligation-based block shuffling. Protein Eng., 2002, 15, 843-853 (Pubitemid 36043227)
18. Kyte, J.; Doolittle, R.F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol., 1982, 157, 105-132
19. Kitamura, K.; Yoshida, C.; Nishigaki, K. GFPs of insertion mutation generated by molecular size-altering block shuffling. FEBS Lett., 2003, 555, 483-488 (Pubitemid 37532597)
20. Haber, E.; Bennett, J.C. Polarization of fluorescence as a measure of antigen-antibody interaction. Proc. Natl. Acad. Sci. USA, 1962, 48, 1935-1942
21. Weber, G. Polarization of the fluorescence of macromolecules. I. Theory and experimental method. BioChem. J., 1952, 51, 145-155
22. England, T.E.; Uhlenbeck, O.C. Enzymatic oligoribonucleotide synthesis with T4 RNA ligase. BioChem.istry, 1978, 17, 2069-2076 (Pubitemid 8341127)